Frequently Asked Questions Is the burning sensation from tirzepatide injection normal
Tirzepatide, a dual GLP-1 and GIP receptor agonist, works through a structured dosing progression that begins at a low level and increases every four weeks
Semaglutide uses a short, thin needle (27-31 gauge) that penetrates only the subcutaneous fat layer just beneath the skin, not muscle or deeper tissue
One study presented at AAOS 2026 Annual Meeting found GLP-1s may help improve postoperative outcomes after certain orthopedic procedures
Key Takeaways Retatrutide is a new triple receptor agonist for GLP-1, GIP, and glucagon receptors to aid appetite regulation and weight loss
CRP measurements, if checked, may show the beginnings of a downward trend